Researchers develop quinoline-based drug with inhibitory activity against the SARS-CoV-2 papain-like protease (PLpro).
New quinoline-based antiviral shows strong promise against SARS-CoV-2
- Post author:admin
- Post published:April 10, 2025
- Post category:uncategorized
- Post comments:0 Comments